A Chinese cohort study uncovers that non-high-density lipoprotein cholesterol ratios and uric acid may signal different biological pathways to developing type 2 diabetes, with implications for improved risk screening.
A large Chinese cohort study published in BMC Endocrine Disorders suggests that two routine blood markers may point to type 2 diabetes through different biological routes: one appears to matter largely because of excess weight, while the other carries an independent signal even after body mass index is taken into account.
The research, led by Weiqiang Qin and colleagues at Sun Yat-sen Memorial Hospital, used data from the China Health and Retirement Longitudinal Study, a nationally representative survey of adults aged 45 and over. More than 8,000 participants were free of diabetes at the start of the study, and 6,762 remained in the fully adjusted analysis after accounting for missing data and follow-up losses.
The investigators compared serum uric acid with the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio, or NHHR, a measure that captures the balance between atherogenic and protective lipids. Using Cox regression, restricted cubic splines and mediation analysis, they tested whether each marker predicted new diabetes cases and how much of that relationship might run through body weight.
The results were uneven. NHHR remained independently associated with incident type 2 diabetes after full adjustment, while the link between uric acid and diabetes weakened once other factors, including body mass index, were added to the model. In the mediation analysis, only about a quarter of NHHR’s association with diabetes was explained by body mass index, whereas just over half of uric acid’s association appeared to run through that pathway.
That distinction matters because it suggests uric acid may often be acting as a companion of obesity rather than a separate driver of diabetes risk. NHHR, by contrast, seemed to retain meaning even among people whose weight did not obviously signal danger. The authors said the ratio may be particularly useful in metabolically abnormal people with normal body mass index, a group that standard screening can overlook.
The study also fits into a wider wave of research on lipid and uric acid ratios as metabolic markers. A 2024 paper in Lipids in Health and Disease found that a uric acid to HDL cholesterol ratio was linked with diabetes risk in U.S. adults, with differences by sex and possible mediation through inflammation, triglycerides and insulin resistance. Other recent studies in NHANES data have associated NHHR with coronary heart disease and mortality, underlining its growing appeal as a broad marker of cardiometabolic risk.
Still, the new work stops short of suggesting immediate changes to practice. The addition of NHHR to a base prediction model brought only modest gains, and the authors stressed that the finding needs confirmation in independent cohorts. The analysis was also observational, so it can show association rather than prove cause.
Even so, the paper adds a useful nuance to diabetes risk assessment: not all abnormal blood markers travel the same path. Uric acid may often reflect the burden of excess weight, while NHHR appears to speak more directly to the metabolic processes that can lead to diabetes.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
